A Clinical Study of Hyperthyroidism in Children
A Retrospective and Prospective Observational Study of Hyperthyroidism in Children
Shengjing Hospital
1,000 participants
Jul 18, 2023
OBSERVATIONAL
Conditions
Summary
This study intends to conduct a retrospective and prospective study on children with hyperthyroidism, and it is a non-intervention study to collect information on diagnosis and treatment and long-term follow-up of children with hyperthyroidism. To investigate the clinical characteristics, treatment effect, side effects and remission of hyperthyroidism in children, to analyze the predictive factors for the effect of antithyroid drug treatment, remission and recurrence after drug withdrawal, and to explore the risk factors related to the occurrence of antithyroid drug-related adverse reactions.
Eligibility
Inclusion Criteria2
- Age ≤14 years old
- Initial diagnosis of hyperthyroidism
Exclusion Criteria3
- Hyperthyroidism had been treated with medication in other hospitals,
- History of autoimmune hepatitis, viral hepatitis, hematological diseases, bone marrow or liver transplantation,
- Patients with incomplete clinical data
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The initial dose of methimazole was 0.2-0.8 mg/(kg▪d). This dose was subsequently reduced by 25% to 50% and adjusted to maintain euthyroidism, based on the results of serum thyroid hormone testing during follow-up.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06570967